Astrazeneca Pharma India Ltd (ASTRAZEN) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

AstraZeneca Pharma India Ltd (AstraZeneca), a subsidiary of AstraZeneca Plc, is a biopharmaceutical company that discovers, develops, and commercializes medicines. The company offers products in the therapeutic areas of cardiovascular and metabolic diseases, respiratory, maternal healthcare, oncology, infection, neuroscience, and gastrointestinal. Its cardiovascular and metabolic disease products include candesartan cilexetil, ticagrwlor, exenatide, rosuvastatin, felodipine, metoprolo succinate, pramlintide acetate, and atenolol, among others. AstraZeneca offers oncology products such as anastrozole tablets, tamoxifen tablets, gefitinib tablets, goserelin acetate injection, goserelin acetate depot injection, bicalutamide tablets, and fulvestrant injection. The company operates in China, Hong Kong, India, Singapore, Thailand, Canada, Chile, Colombia, Mexico, the US, and Mauritius, among others. AstraZeneca is headquartered in Bangalore, Karnataka, India.

Astrazeneca Pharma India Ltd (ASTRAZEN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Sun Pharma Enters into Co-Marketing Agreement with AstraZenceca Pharma for Dapagliflozin 10
Sun Pharma Enters into Distribution Agreement with Astrazeneca Pharma 11
Dr Reddys Labs Enters into Distribution Agreement with Astrazeneca Pharma 12
Asset Transactions 13
Zydus Cadila Healthcare May Acquire 8 brands from Astrazeneca India 13
Acquisition 14
AstraZeneca To Acquire Remaining 10% Stake In Astrazeneca Pharma India 14
Astrazeneca Pharma India Ltd - Key Competitors 15
Astrazeneca Pharma India Ltd - Key Employees 16
Astrazeneca Pharma India Ltd - Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Financial Announcements 18
May 09, 2017: AstraZeneca Pharma India Reports Total Income From Operations Of INR5.4 Billion In Fiscal 2017 18
Corporate Communications 19
Aug 08, 2017: AstraZeneca Appoints Mr. Ian John Parish to its Board of Director 19
Jun 29, 2017: AstraZeneca Announces Board Change 20
Other Significant Developments 21
May 17, 2018: AstraZeneca strengthens innovation partnership in India 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List Of Tables


Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Astrazeneca Pharma India Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sun Pharma Enters into Co-Marketing Agreement with AstraZenceca Pharma for Dapagliflozin 10
Sun Pharma Enters into Distribution Agreement with Astrazeneca Pharma 11
Dr Reddys Labs Enters into Distribution Agreement with Astrazeneca Pharma 12
Zydus Cadila Healthcare May Acquire 8 brands from Astrazeneca India 13
AstraZeneca To Acquire Remaining 10% Stake In Astrazeneca Pharma India 14
Astrazeneca Pharma India Ltd, Key Competitors 15
Astrazeneca Pharma India Ltd, Key Employees 16

List Of Figures


Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Astrazeneca Pharma India Ltd (ASTRAZEN) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

AstraZeneca Pharma India Ltd (AstraZeneca), a subsidiary of AstraZeneca Plc, is a biopharmaceutical company that discovers, develops, and commercializes medicines. The company offers products in the therapeutic areas of cardiovascular

USD 250 View Report

Astrazeneca PLC Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Astrazeneca PLC Company Profile is a detailed strategic and analytical report on Astrazeneca PLC. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200 View Report

Astrazeneca Pharma India Limited Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Astrazeneca Pharma India Limited Company Profile is a detailed strategic and analytical report on Astrazeneca Pharma India Limited. The 2018 version of the report offers detailed insights into the companys

USD 200 View Report

Astrazeneca Pharma India Limited Strategic Analysis Review- Astrazeneca Pharma India Limited SWOT, Outlook, Operations and Financial Profile

Astrazeneca Pharma India Limited Company Profile provides strategic analysis of Astrazeneca Pharma India Limited Company in current market conditions. The companys business/ operational/growth strategies are analyzed in the unique research

USD 200 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available